Henry Schein, Inc. $HSIC Stake Lessened by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,635 shares of the company’s stock after selling 6,629 shares during the period. PNC Financial Services Group Inc.’s holdings in Henry Schein were worth $5,869,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Assenagon Asset Management S.A. boosted its position in Henry Schein by 212.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 67,181 shares of the company’s stock worth $5,078,000 after acquiring an additional 45,701 shares during the period. Tudor Investment Corp ET AL purchased a new position in Henry Schein during the 3rd quarter valued at about $15,375,000. Heartland Advisors Inc. acquired a new position in shares of Henry Schein in the 4th quarter valued at about $9,070,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Henry Schein by 15.8% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 115,279 shares of the company’s stock valued at $8,856,000 after purchasing an additional 15,765 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in shares of Henry Schein by 10,448.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 42,193 shares of the company’s stock valued at $3,189,000 after purchasing an additional 41,793 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Citigroup began coverage on shares of Henry Schein in a report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price target for the company. Mizuho dropped their price objective on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Robert W. Baird set a $97.00 target price on shares of Henry Schein in a research report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. Finally, BTIG Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Thursday, June 11th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $88.62.

Insider Transactions at Henry Schein

In other Henry Schein news, Director William K. Daniel bought 10,000 shares of Henry Schein stock in a transaction on Monday, May 11th. The stock was purchased at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the purchase, the director directly owned 20,000 shares of the company’s stock, valued at $1,383,800. The trade was a 100.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.89% of the stock is owned by company insiders.

Henry Schein Price Performance

HSIC opened at $85.47 on Monday. The company has a market capitalization of $9.74 billion, a PE ratio of 25.82, a price-to-earnings-growth ratio of 1.65 and a beta of 0.81. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.36 and a quick ratio of 0.75. Henry Schein, Inc. has a fifty-two week low of $61.94 and a fifty-two week high of $89.34. The business has a 50-day moving average of $80.98 and a 200-day moving average of $78.03.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.20 by $0.12. The business had revenue of $3.37 billion during the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 5.32 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.